(Henderson, Nev.; June 4, 2012) – St. Rose Dominican Hospitals is leading the valley in its performance of minimally-invasive heart procedures, including the new TAVR procedure, giving patients options for their cardiac care.
St. Rose has successfully completed the SAPIEN Transcatheter Aortic Valve Replacement (TAVR) procedure on several patients, allowing those patients a non-surgical option when surgery could not be performed. The TAVR procedure was approved by the FDA in November 2011 as a therapy for adult patients with severe symptomatic aortic stenosis who were determined inoperable for open heart aortic valve replacement surgery by their cardiac surgeons. With the recent opening of St. Rose’s hybrid OR, TAVR is now available for adult patients who are not candidates for traditional open-heart surgery.
“A multi-disciplinary ‘TAVR Heart Team,’ led by cardiothoracic surgeons and interventional cardiologists, is bringing the highest level of heart care to our community,” said Rod Davis, president and CEO of St. Rose Dominican Hospitals and senior vice president of operations, Dignity Health Nevada. “This is another way that St. Rose is meeting the needs of the community and giving physicians the tools they need to care for their patients.”
Up to 1.5 million people in the United States suffer from Aortic Stenosis (AS), and approximately one-third of those suffer from severe AS (usually patients older than 75) which means surgical aortic valve replacement (AVR) is necessary. Studies show that without an AVR, 50 percent of those patients with severe AS will not survive more than two years after symptoms begin.
“The support of St. Rose Dominican Hospitals made this new procedure possible for our patients,” said Dr. Herb Cordero, cardiologist. “Cardiologists and cardiovascular surgeons at St. Rose now have the newest technology and procedures to treat patients who would otherwise be too ill for lifesaving surgeries.”
Prior to the approval of TAVR by the FDA, there were no treatment options available for patients who were inoperable because of factors such as age, history of heart disease, frailty or other issues. TAVR enables the placement of a collapsible aortic heart valve into the body via a catheter inserted near the groin rather than by open heart surgery – a much less invasive method of delivery.